Cancer’s cruelest trick is its ability to disappear, only to reappear years later in a new organ or a familiar scar. The fear ...
A research team at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) has developed a radiopharmaceutical molecule marker that ...
New research presented at the 2025 International Kidney Cancer Symposium found that patients with localized renal cell ...
New research from University of Lucknow and King George’s Medical University shows that specific protein markers involved in ...
Pfizer Inc. (NYSE:PFE) is one of the most buzzing stocks to invest in according to hedge funds. Earlier on December 17, ...
A recent study reveals comparable outcomes for radical cystectomy and bladder-sparing therapy in treating recurrent ...
Gallbladder cancer is a rare and often aggressive malignancy that develops in the tissues of the gallbladder — a small, ...
A UK-led international clinical trial is recruiting 280 patients to see if the technique to remove cancerous cells could ...
The last time I spoke about Pfizer (PFE), it was with respect to a Seeking Alpha article. With respect to this article, I wrote about the company making a bid to acquire Metsera for two candidates it ...